Status | Study |
Recruiting |
Study Name: Safety Study of Anti-LAG-3 in Relapsed or Refractory Hematologic Malignancies Condition: Hematologic Neoplasms Date: 2014-02-12 Interventions: Biological: BMS-986016 Other N |
Active, not recruiting |
Study Name: Phase 1/2 Study of AG-221 in Subjects With Advanced Hematologic Malignancies With an IDH2 Mutation Condition: Hematologic Neoplasms Date: 2013-07-31 Interventions: Drug: AG-221 AG-221 administered orally on every day of 28 day cycles until disease progression or unacc |
Active, not recruiting |
Study Name: Feasibility Study of Genomic Sequencing to Find Potential Targets for Personalized Therapy Condition: Hematologic Neoplasms Date: 2013-05-28 |
Active, not recruiting |
Study Name: Study to Allow Access to Single Agent Panobinostat for Patients Who Are on s.a. Panobinostat Treatment in a Novartis-sponsored Study and Are Benefiting From the Treatment as Judged by the Investigator Condition: Hematologic Neoplasms Date: 2013-02-26 Interventions: Drug: Panobinostat single agent panobinostat starting with last assigned dose and regimen which patient |
Active, not recruiting |
Study Name: Intra-bone Cord Blood Transplantation in Patients With Haematological Malignancies Condition: High Risk Haematological Malignancies Advanced Date: 2012-06-04 Interventions: Procedure: Intrabone Allogeneic Transplant Unrelated single unit intrabone cord blood transplantation |
Completed |
Study Name: Biomarker Research for Personalized Medicine Condition: Hematologic Neoplasms Date: 2011-12-06 |
Recruiting |
Study Name: Hematopoietic Cell Transplantation for Patients With Hematologic Malignancies Using Related, HLA-Haploidentical Donors Condition: Hematologic Neoplasms Date: 2011-06-15 Interventions: Drug: Cyclophosphamide 14.5 mg |
Active, not recruiting |
Study Name: National Marrow Donor Program Long-Term Donor Follow-Up Condition: Hematologic Neoplasms Date: 2011-05-26 |
Recruiting |
Study Name: Intra-bone Cord Blood Transplantation Condition: Hematologic Neoplasms Date: 2011-04-06 Interventions: Procedure: Intrabone injection |
Completed |
Study Name: Symptom Experience and Self-management After Haematopoietic Stem Cell Transplantation Condition: Hematologic Neoplasms Date: 2011-01-03 |